Form 8-K - Current report:
SEC Accession No. 0001654954-24-013107
Filing Date
2024-10-18
Accepted
2024-10-18 17:26:47
Documents
15
Period of Report
2024-10-17
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 24098
  Complete submission text file 0001654954-24-013107.txt   160226

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zivo-20241017.xsd EX-101.SCH 6166
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20241017_lab.xml EX-101.LAB 15863
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20241017_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20241017_pre.xml EX-101.PRE 11609
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20241017_def.xml EX-101.DEF 4218
17 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 5425
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

EIN.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 241381527
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)